Abstract
Mechanical strain reportedly stimulates the synthesis of collagen in vascular smooth muscle cells (SMCs). The present study was designed to investigate a possible involvement of angiotensin II (Ang II) and transforming growth factor (TGF)-β in stretch-induced collagen synthesis of cultured SMCs derived from the rabbit aortic media. SMCs were cyclically stretched at a rate of 10% elongation and 30 cycles/min for 24 h using the Flexercell® strain unit (Flexcell International Corp., McKeesport, Pa.). A two-fold increase in collagen synthesis and a concurrent increase in total protein synthesis were noted in stretched SMCs. Concentration of immunoreactive Ang II in the conditioned medium was elevated under the mechanical strain. Stretch-induced collagen and total protein synthesis were inhibited by either a selective antagonist to Ang II (saralasin), an angiotensin I-converting enzyme inhibitor (captopril) or an antisense oligonucleotide for angiotensinogen mRNA. An elevated secretion of TGF-β, both active and latent forms, was found in the medium of stretched SMCs. Saralasin inhibited the stretch-induced secretion of TGF-β from SMCs. Stretch-induced collagen and total protein synthesis was further inhibited by either an anti-TGF-β1 neutralizing antibody or an adenovirus-mediated transfer of a truncated TGF-β type II receptor. Elevated expression of collagen α1(III) chain and TGF-β1 mRNAs, and its reversal by saralasin were also demonstrated in stretched SMCs. Results indicate that the stretch-induced collagen and total protein synthesis appears to be mediated via an autocrine-paracrine mechanism of Ang II and TGF-β released from SMCs.
References
1.
Gibbons GH, Dzau VJ: The emerging concept of vascular remodeling. N Eng J Med 1994;330:1431–1438.
2.
Ooshima A, Fuller GC, Cardinale GJ, Spector S, Udenfriend S: Increased collagen synthesis in blood vessels of hypertensive rats and its reversal by antihypertensive agents. Proc Natl Acad Sci USA 1974;71:3019–3023.
3.
Fuller GC, Matoney AL, Fisher DO, Fausto N, Cardinale GJ: Increased collagen synthesis and kinetic characteristics of prolyl hydroxylase in tissues of rabbits with experimental atherosclerosis. Atherosclerosis 1976;24:483–490.
4.
Leung DY, Glagov S, Mathews MB: Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science 1976;191:475–477.
5.
Sumpio BE, Banes AJ, Link WG, Johnson G: Enhanced collagen production by smooth muscle cells during repetitive mechanical stretching. Arch Surg 1988;123:1233–1236.
6.
Birukov KG, Shirinsky VP, Stepanova OV, Tkachuk VA, Hahn AWA, Resink TJ, Smirnov VN: Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem 1995;144:131–139.
7.
Carver W, Nagpal ML, Nachtigal M, Borg TK, Terracio L: Collagen expression in mechanically stimulated cardiac fibroblasts. Circ Res 1991;69:116–122.
8.
Bruce BL, Cortex P, Zhao X, Bernstein J, Dumler F, Narins RG: Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992;90:1932–1943.
9.
Russel R: The pathogenesis of atherosclerosis: A perspective for 1990s. Nature 1993;362:801–809.
10.
Kifor I, Dzau VJ: Endothelial renin-angiotensin pathway: Evidence for intracellular synthesis and secretion of angiotensins. Circ Res 1987;60:422–428.
11.
Re RN, Fallon JT, Dzau VJ, Quay S, Haber E: Renin synthesis by canine aortic smooth muscle cells in culture. Life Sci 1982;30:99–106.
12.
Lindpainter K, Ganten D: The cardiac renin-angiotensin system. Circ Res 1991;68:905–921.
13.
Baker KM, Booz GW, Dostal DE: Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. Annu Rev Physiol 1992;54:227–241.
14.
Morishita R, Higashi J, Miyazaki M, Ogihara T: Possible role of the vascular renin-angiotensin in hypertension and vascular hypertrophy. Hypertension 1992;19(suppl II):II-62–II-67.
15.
Geisterfer AAT, Peach MJ, Owens GK: Angiotensin II induces hypertrophy not hyperplasia of cultured rat aortic smooth muscle cells. Circ Res 1988;62:749–756.
16.
Berk BC, Vekshtein V, Gordon HM, Tsuda T: Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989;13:305–314.
17.
Kato H, Suzuki H, Tajima S, Ogata Y, Tomonaga T, Sato A, Saruta T: Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 1991;9:17–22.
18.
Sadoshima J, Jahn L, Takahasi T, Kulik T, Izumo S: Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. J Biol Chem 1992;1267:10551–10560.
19.
Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993;75:977–984.
20.
Roberts AB, Flanders KC, Kondaiah P, Thompson NL, Obberghen-Schilling EV, Wakefield L, Rossi P, de Crombrugghe B, Heine U, Sporn MB: Transforming growth factor β: Biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. Recent Prog Horm Res 1988;44:157–197.
21.
Ignotz RA, Massagué J: Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337–4345.
22.
Sarzani R, Brecher P, Chobanian AV: Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest 1989;83:1404–1408.
23.
Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA: Production of transforming growth factor β1 during repair of arterial injury. J Clin Invest 1991;88:904–910.
24.
Wolf G, Haberstroh U, Neilson EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 1992;140:95–107.
25.
Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 1994;93:2431–2437.
26.
Ohno M, Cooke JP, Dzau VJ, Gibbons GH: Fluid shear stress induces endothelial transforming growth factor beta-1 transcription. Modulation by potassium channel blockade. J Clin Invest 1995;95:1363–1369.
27.
Malek AM, Izumo S: Molecular aspects of signal transduction of shear stress in the endothelial cell. J Hypertens 1994;12:989–999.
28.
Owens GK, Loeb A, Gordon D, Thompson MM: Expression of smooth muscle-specific α-isoactin in cultured vascular smooth muscle cells: Relationship between growth and cytodifferentiation. J Cell Biol 1986;102:343–352.
29.
Banes AJ, Gilbert J, Taylor D, Monbureau O: A new vacuum-operated stress-providing instrument that applies static or variable duration cyclic tension or compression to cells in vitro. J Cell Sci 1985;75:35–42.
30.
Gilbert JA, Weinhold PS, Banes AJ, Link GW, Jones GL: Strain profiles for circular cell culture plates containing flexible surfaces employed to mechanically deform cells in vitro. J Biochem 1994;27:1169–1977.
31.
McLimans WF, Davis EV, Glover FL, Rake GW: The submerged culture of mammalian cells: The spinner culture. J Immunol 1957;79:428–433..
32.
Green LM, Reade JL, Warl CF: Rapid colorimetric assay for cell viability: Application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods 1984;70:257–268.
33.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
34.
Burton K: A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 1954;62:315–323.
35.
Peterkofsky B, Diegelman R: Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 1971;10:988–993.
36.
Barnes MJ, Morton LF, Levene CI: Synthesis of collagens types I and III by pig medial smooth muscle cells in culture. Biochem Biophys Res Commun 1976;70:339–347.
37.
Sykes B, Puddle B, Francis M, Smith R: The estimation of two collagens from human dermis by interrupted gel electrophoresis. Biochem Biophys Res Commun 1976;72:1472–1480.
38.
Saito H, Nakamaru M, Ogihara T, Rakugi H, Kumahara Y, Shimamoto K, Miyazaki M, Inagami T: Renin inhibitor and converting enzyme inhibitors suppress vascular angiotensin II. Hypertension 1989;13:749–753.
39.
Cain MD, Coghlan JP, Catt KJ: Measurement of angiotensin II in blood by radioimmunoassay. Clin Chim Acta 1971;39:21–31.
40.
DeSilva PE, Usan A, Smegy RR, Khairallah PA: Measurement of immunoreactive angiotensin peptides in rat tissues: Some pitfalls in angiotensin II analysis. Anal Biochem 1988;174:80–87.
41.
Lyons RM, Keski-Oja J, Moses HL: Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J Cell Biol 1988;106:1659–1665.
42.
Kageyama R, Ohkubo H, Nakanishi S: Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence. Biochemistry 1984;23:3603–3609.
43.
Chiang M-Y, Chan H, Zounes MA, Freier SM, Lima WF, Bennett CF: Antisense oligonucleotides inhibit intracellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem 1991;266:18162–18171.
44.
Yamamoto H, Ueno H, Ooshima A, Takeshita A: Adenovirus-mediated transfer of a truncated transforming growth factor (TGF)-β type II receptor completely and specifically abolishes diverse signaling by TFG-β in vascular wall cells in primary culture. J Biol Chem 1996;271:16253–16259.
45.
Ueno H, Li J-J, Tomita H, Yamamoto H, Pan Y, Kanegae Y, Saito I, Takeshita A: Quantitative analysis of repeat adenovirus-mediated gene transfer into injured canine femoral arteries. Arterioscler Thromb Vasc Biol 1995;15:2246–2253.
46.
Braun L, Mead JE, Panzica M, Mikamo R, Bell BI, Fausto N: Transforming growth factor β mRNA increases during liver regeneration: A possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 1988;85:1539–1543.
47.
Timmermans PB, Smith RD: Angiotensin II receptor subtypes: Selective antagonists and functional correlates. Eur Heart J 1994;15:79–87.
48.
Villarreal FJ, Kim NN, Ungab GD, Prontz MP, Dillmann WH: Identification of functional angiotensin II receptors on cardiac fibroblasts. Circulation 1993;88:2849–2861.
49.
de Gasparo M, Whitebread S, Mele M, Motani AS, Whitcombe PJ, Ramjoue HP, Kamber B: Biochemical characterization of two angiotensin II receptor subtypes in the rat. J Cardiovasc Pharmacol 1990;16(suppl 4):S31–S35.
50.
Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DH, Ross R: TGF-beta induces bimodal proliferation of connective tissue cells via complex control of autocrine PDGF loop. Cell 1990;63:515–524.
51.
Naftilan AJ, Pratt RE, Dzau VJ: Induction of platelet-derived growth factor A-chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1419–1424.
52.
Taubman MB, Berk BC, Izumo S, Tsuda T, Alexander RW, Nadal-Ginard B: Angiotensin II induced c-fos mRNA in aortic smooth muscle. J Biol Chem 1989;264:526–530.
53.
Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ: Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993;91:2268–2274.
54.
Owens GK, Geisterfer AAT, Yang YW-H, Komoriya A: Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol 1988;107:771–780.
55.
Gibbons GH, Pratt RE, Dzau VJ: Vascular smooth muscle cell hypertrophy vs. hyperplasia. J Clin Invest 1992;90:456–461.
56.
Lansman JB, Hallam TJ, Rink TJ: Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers? Nature 1987;325:811–813.
57.
Davis MJ, Meininger GA, Zawieja DC: Stretch-induced increases in intracellular calcium of isolated vascular smooth muscle cells. Am J Physiol 1992;263:H1292–H1299.
58.
Wang N, Butler JP, Ingber DE: Mechanotransduction across the cell surface and through the cytoskeleton. Science 1993;260:1124–1127.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
